Efficacy and safety of intravenous neridronic acid in CRPS

Registry ID

EUCTR2017-004244-37

Source registry

EUCTR

Status

Completed

Phase

PHASE3

Sponsor

Grünenthal GmbH

Start date

2018-08-16

Completion date

2019-08-01

Last update

2026-08-16

Conditions

• Complex Regional Pain Syndrome (CRPS)

Summary

To demonstrate the superior efficacy of a cumulative dose of 400 mg intravenous neridronic acid versus placebo for the treatment of CRPS-related pain.

Locations

• , , Slovakia
• , , Czechia

Related clinical trials

• Effectiveness of Transcranial Direct Current Stimulation (tDCS) in the Management of Complex Regional Pain Syndrome
• Peripersonal Space Representation in Upper Limb Segmental Exclusion

View on source registry